Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L MacDonald

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse modelYunhong Huang, Thais Rafael Guimarães, Nicholas Todd, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
PACS1 syndrome variant alters proteomic landscape of developing cortical organoidsXimena Gomez-Maqueo, Lauren E Rylaarsdam, Ashley Woo, et al.
Plos One|April 17, 2009
The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnessesChang-Gyu Hahn, Anamika Banerjee, Matthew L Macdonald, et al.
Journal of Neuropathology and Experimental Neurology|January 16, 2016
Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar DegenerationCaitlin M Kirkwood, Matthew L MacDonald, Tadhg A Schempf, et al.
Biological Psychiatry|March 31, 2015
Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in SchizophreniaMicah A Shelton, Jason T Newman, Hong Gu, et al.
Molecular & Cellular Proteomics : MCP|April 23, 2016
Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer DiseaseRobert A Sweet, Matthew L MacDonald, Caitlin M Kirkwood, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Circadian rhythm disruptions associated with opioid use disorder in the synaptic proteomes of the human dorsolateral prefrontal cortex and nucleus accumbensStephanie Puig, Xiangning Xue, Ryan Salisbury, et al.
Molecular Psychiatry|September 6, 2023
Circadian rhythm disruptions associated with opioid use disorder in synaptic proteomes of human dorsolateral prefrontal cortex and nucleus accumbensStephanie Puig, Xiangning Xue, Ryan Salisbury, et al.
Neurobiology of Disease|August 3, 2023
Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brainJoshua M Lorenz-Guertin, Nadya Povysheva, Caitlyn A Chapman, et al.
The American Journal of Psychiatry|May 7, 2019
Increased Protein Insolubility in Brains From a Subset of Patients With SchizophreniaLeslie G Nucifora, Matthew L MacDonald, Brian J Lee, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse modelYunhong Huang, Thais Rafael Guimarães, Nicholas Todd, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
PACS1 syndrome variant alters proteomic landscape of developing cortical organoidsXimena Gomez-Maqueo, Lauren E Rylaarsdam, Ashley Woo, et al.
Plos One|April 17, 2009
The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnessesChang-Gyu Hahn, Anamika Banerjee, Matthew L Macdonald, et al.
Journal of Neuropathology and Experimental Neurology|January 16, 2016
Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar DegenerationCaitlin M Kirkwood, Matthew L MacDonald, Tadhg A Schempf, et al.
Biological Psychiatry|March 31, 2015
Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in SchizophreniaMicah A Shelton, Jason T Newman, Hong Gu, et al.
Molecular & Cellular Proteomics : MCP|April 23, 2016
Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer DiseaseRobert A Sweet, Matthew L MacDonald, Caitlin M Kirkwood, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Circadian rhythm disruptions associated with opioid use disorder in the synaptic proteomes of the human dorsolateral prefrontal cortex and nucleus accumbensStephanie Puig, Xiangning Xue, Ryan Salisbury, et al.
Molecular Psychiatry|September 6, 2023
Circadian rhythm disruptions associated with opioid use disorder in synaptic proteomes of human dorsolateral prefrontal cortex and nucleus accumbensStephanie Puig, Xiangning Xue, Ryan Salisbury, et al.
Neurobiology of Disease|August 3, 2023
Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brainJoshua M Lorenz-Guertin, Nadya Povysheva, Caitlyn A Chapman, et al.
The American Journal of Psychiatry|May 7, 2019
Increased Protein Insolubility in Brains From a Subset of Patients With SchizophreniaLeslie G Nucifora, Matthew L MacDonald, Brian J Lee, et al.
Pageof 5